 |
Eliem Therapeutics
Last updated: September 15, 2024
Bob Azelby, CEO
USA | Funding: $411.3M (+)
Website: https://www.eliemtx.com/
Eliem Therapeutics plans to treat chronic pain, depression, epilepsy and anxiety with palmitoylethanolamide (PEA) prodrug
Website: https://www.eliemtx.com/
Eliem Therapeutics plans to treat chronic pain, depression, epilepsy and anxiety with palmitoylethanolamide (PEA) prodrug
